Cite
HARVARD Citation
Wang, L. et al. (2019). Bevacizumab synergises with the BCL 2 inhibitor venetoclax to effectively treat B‐cell non‐Hodgkin's lymphoma. European journal of haematology. pp. 234-246. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wang, L. et al. (2019). Bevacizumab synergises with the BCL 2 inhibitor venetoclax to effectively treat B‐cell non‐Hodgkin's lymphoma. European journal of haematology. pp. 234-246. [Online].